Acute on chronic liver failure

4 trials MedDRA PT
4 Registered trials
0 Recruiting
3 Unique sponsors
4 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
N Neurology/Psychiatry (ATC N) 2
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Colony-stimulating factor 1 substance
Phase II: 4

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase II

4 trials
  • Cellaïon SA Commercial
    HHALPC
    2022-500252-28-00 14 countries 2019 n=132
    Ended
  • Versantis AG Commercial
    CITRIC ACID, ANHYDROUS PH. EUR.
    2024-513706-56-00 6 countries 2023 n=102 Orphan
    Ended
  • Versantis AG Commercial
    CITRIC ACID, ANHYDROUS PH. EUR.
    2025-521029-34-00 4 countries 2025 n=30
    Ended
  • Alpha Bioresearch S.L. Academic
    FILGRASTIM; RESATORVID
    2022-501026-37-00 3 countries n=50
    Not authorised
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Versantis AG Commercial 2 Phase II 0
Cellaïon SA Commercial 1 Phase II 0
Alpha Bioresearch S.L. Academic 1 Phase II 0
New trials by year
2019
1
2023
1
2025
1
← All indication landscapes